Alzheimer’s
disease is defined as an advanced neurological disorder that increasingly
deprives patients of their memory and ability to carry out daily activities. As
it grows in a human brain, individuals are likely to practice difficulties in
linguistic, agility and insight along with negative changes in the character
and performance such as depression, anxiety, delusion, hallucination and
agitation. Alzheimer's disease is the main source of dementia all over the
world and can be either a major or a mild neurocognitive disorder. Alzheimer’s
is likely to grow exponentially with increase in ageing population thus,
providing a significant market opportunity in the coming years.
The
current market for Alzheimer’s disease drugs is limited as only few drugs have
been approved thus, defining a healthy scope of introduction of new drugs in
the market in the coming years. The healthcare costs associated with
Alzheimer’s are also anticipated to rise considerably since only limited
treatment options are available in the market. The Alzheimer market expects
introduction of innovative small molecules, biopharmaceuticals and disease
modifying agents that would help transform the pattern of Alzheimer’s disease.
Purchase a copy of Global Alzheimer Market visit @
http://www.orbisresearch.com/contact/purchase/36204 For more information contact sales@orbisresearch.com
Increasing
ageing population, growing population of women, rising life expectancy,
increasing healthcare expenditure, improving economic conditions, and
increasing global spending on medicines are some of the major factors
contributing to the growth of Alzheimer’s disease market. However, the growth
of the market is hindered by certain challenges including lack of availability
of effective treatment options, problems in detection and diagnosis, and
insufficient research funding.
The
report, “Global Alzheimer Market” analyzes the currently prevailing condition
of the market along with its future scope of development. The global market
along with specific markets of the U.S., Europe (including the UK) and
Asia-Pacific are being discussed in the report. The major trends, growth
drivers as well as issues being faced by the industry are being presented in
this report. The major players in the industry are being profiled, along with
their key financials and strategies for growth.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-alzheimer-market-report-2015-edition
Some points from TOC:
1 Overview
1.1 Definition of Dementia
1.1.1 Causes of Dementia
1.1.2 Types of Dementia
1.2 Definition of Alzheimer
1.2.1 Brain Changes Related to Alzheimer
1.2.2 Risks Associated with Alzheimer
1.2.3 Symptoms of Alzheimer
1.2.4 Diagnosis of Alzheimer
1.2.5 Stages of Alzheimer
1.2.6 Treatment Options for Alzheimer’s disease
1.2.7 Currently Available Drugs for Alzheimer Disease
1.1 Definition of Dementia
1.1.1 Causes of Dementia
1.1.2 Types of Dementia
1.2 Definition of Alzheimer
1.2.1 Brain Changes Related to Alzheimer
1.2.2 Risks Associated with Alzheimer
1.2.3 Symptoms of Alzheimer
1.2.4 Diagnosis of Alzheimer
1.2.5 Stages of Alzheimer
1.2.6 Treatment Options for Alzheimer’s disease
1.2.7 Currently Available Drugs for Alzheimer Disease
2. Market Analysis
2.1 Global Dementia Market
Global Dementia Population
Population by Region & Income
Dementia Expenditure Growth
2.2 Global Alzheimer Market
Market Value
Market Share by Drug Classes
2.1 Global Dementia Market
Global Dementia Population
Population by Region & Income
Dementia Expenditure Growth
2.2 Global Alzheimer Market
Market Value
Market Share by Drug Classes
3. Regional Markets
3.1 The U.S.
Alzheimer Prevalence
Prevalence by Stage & Age Group
Alzheimer Cost by Channel
Death Rate
Market Opportunity for New Drugs
3.2 AsiaPacific
Dementia Population by Countries
Dementia Expenditure by Countries
3.3 Europe
Alzheimer Prevalence
3.3.1 The UK
Dementia Prevalence
Prevalence by Type
Dementia Cost Breakup
3.1 The U.S.
Alzheimer Prevalence
Prevalence by Stage & Age Group
Alzheimer Cost by Channel
Death Rate
Market Opportunity for New Drugs
3.2 AsiaPacific
Dementia Population by Countries
Dementia Expenditure by Countries
3.3 Europe
Alzheimer Prevalence
3.3.1 The UK
Dementia Prevalence
Prevalence by Type
Dementia Cost Breakup
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter:
https://twitter.com/orbisresearch
Like us on Facebook:
https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment